B For the Years Ended December 31, 2020 and 2019 $ in millions 4 5 6 2020 2019 $ 56,009 $ 53,342 32,060 29,963 23,949 23,379 7 Revenue 8 Net sales 9 Cost of merchandise sold 10 Gross Profit 11 12 Operating Expenses 13 Selling, general and administrative 14 Depreciation 15 Operating income 8,000 3,444 12,505 7,541 278 15,560 16 235 1,500 13,770 205 (250) 15,105 17 Interest expense, net 18 Gain/(Loss) on sale of property & equip 19 Income before income taxes 20 21 Provision for income taxes 22 23 Net income 3,442 3,163 2 2 $ 10,827 $ 11,942 2 Balance Sheet 3 December 31, 2020 and 2019 4 $ in millions 5 6 2020 2019 7 Current Assets 8 Cash and cash equivalents $ 27,702 $ 19,496 9 Accounts Receivable, net 4,667 2,420 10 Merchandise inventories 3,725 4,250 11 Other current assets 1,222 450 12 Total Current Assets 37,316 26,616 13 14 Long-Term Assets 15 Property and equipment 15,549 12,049 16 Accumulated depreciation (5,272) (2,828) 17 Intangible assets, net 193 193 18 Total Long-Term Assets 10,470 9,414 19 Total Assets $ 47,786 $ 36,030 20 21 Current Liabilities 22 Accounts payable $ 1,900 $ 1,323 23 Accrued liabilities 985 1,135 24 Income taxes payable 3,442 790 25 Current nortion of long-term debt 135 135 Income Statement Balance Sheet Cash Flow Statement Ratios LG aste BIO a. Av Merge & lipboard Font Alignment 2 Balance Sheet 1,900 $ 985 3,442 135 6,462 1,323 1,135 790 135 3,383 4,752 11,214 6,152 9,535 1 Current Liabilities 2 Accounts payable $ 3 Accrued liabilities 24 Income taxes payable 25 Current portion of long-term debt 26 Total Current Liabilities 27 28 Non-current Liabilities 29 Long-term debt 30 Total Liabilities 31 32 Shareholders' Equity Common stock;.01 par value; 9,000 shares authorized; 380 and 370 shares issued & 33 outstanding respectively 34 Paid-in capital 35 Treasury stock, at cost 36 Retained earnings 37 Total Shareholders' Equity 38 Total Liabilities and Shareholders' Equity $ 39 40 Additional Information: 41 Income Statement Balance Sheet 4 3,727 (10,064) 42,905 36,572 47,786 $ 4 3,227 (9,864) 33,128 26,495 36,030 Cash Flow Statement Ratios 1 Type here to search o i Total Liabilities and Shareholders' Equity 47,786 $ 30,00 ditional Information: The company paid cash dividends of $45 in 2019 and $550 in 2020 The company purchased treasury stock of $200 in cash during 2020, and sold common stock for cash of $500 during 2020. Ne other stock transactions took place The company purchased $7.000 in cash for equipment during the year. In addition, equipment was sold for $4,000 in cash the equipment had a book value at the time of sale of 53,500 There were no purchase or sale of intangible assets. The company made cash payments of $1,900 on its debt obligations, and took an additional $500 in cash of debt during the year 1 2 3 Current Ratio = 4 5 Acid-Test Ratio = 6 7 8 AR Turnover = 9 10 11 Days Sales Uncollected = 12 13 14 Inventory turnover = 15 16 17 Days sales in Inventory = 18 19 20 2 2 Total Asset Turnover = 21 22 File Home Insert Draw Page Layout Formulas Calibri -11 - ' ' Paste BIU Clipboard F Font 5 A32 A B D Debt to Equity = Times Interest Earned 22 23 24 25 26 27 28 29 30 31 32 33 34 Net Profit Margin= Return on Total Assets = 35 36 Ceturn on Stockholders Equity = 37 38 39 40 Earnings per Share (EPS) = 41 43 14 Income Statement Balance Sheet Cash Flow Type here to search